Cyclic nucleotide phosphodiesterases and human arterial smooth muscle cell proliferation.
Rybalkin
S D
SD
Department of Pharmacology, University of Washington, Seattle 98195-7470, USA.
Bornfeldt
K E
KE
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors / Q000502:physiology*; D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors / Q000502:physiology*; D001011:Aorta / Q000166:cytology / Q000502:physiology; D001158:Arteries / Q000166:cytology / Q000502:physiology; D002453:Cell Cycle / Q000502:physiology; D002455:Cell Division / Q000187:drug effects / Q000502:physiology*; D000242:Cyclic AMP / Q000502:physiology*; D006152:Cyclic GMP / Q000502:physiology*; D054677:Cyclic Nucleotide Phosphodiesterases, Type 1; D056746:Cyclin G; D056766:Cyclin G1; D016213:Cyclins; D015870:Gene Expression; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000166:cytology* / Q000502:physiology; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology; D010727:Phosphoric Diester Hydrolases / Q000235:genetics / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology
C534702:CCNG1 protein, human; D056746:Cyclin G; D056766:Cyclin G1; D016213:Cyclins; D010726:Phosphodiesterase Inhibitors; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D054677:Cyclic Nucleotide Phosphodiesterases, Type 1; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D006152:Cyclic GMP